These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35346994)

  • 1.
    Saito T; Itoh M; Tohda S
    Anticancer Res; 2022 Apr; 42(4):1757-1761. PubMed ID: 35346994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tyro3, Axl, and Mertk receptors differentially participate in platelet activation and thrombus formation.
    Zhou J; Yang A; Wang Y; Chen F; Zhao Z; Davra V; Suzuki-Inoue K; Ozaki Y; Birge RB; Lu Q; Wu Y
    Cell Commun Signal; 2018 Dec; 16(1):98. PubMed ID: 30541554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TAM Family Receptor Kinase Inhibition Reverses MDSC-Mediated Suppression and Augments Anti-PD-1 Therapy in Melanoma.
    Holtzhausen A; Harris W; Ubil E; Hunter DM; Zhao J; Zhang Y; Zhang D; Liu Q; Wang X; Graham DK; Frye SV; Earp HS
    Cancer Immunol Res; 2019 Oct; 7(10):1672-1686. PubMed ID: 31451482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galectin-3 Stimulates Tyro3 Receptor Tyrosine Kinase and Erk Signalling, Cell Survival and Migration in Human Cancer Cells.
    Al Kafri N; Hafizi S
    Biomolecules; 2020 Jul; 10(7):. PubMed ID: 32664510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin suppresses the growth of leukemia cells partly through downregulation of AXL receptor tyrosine kinase.
    Saito T; Itoh M; Tohda S
    Leuk Res; 2020 Jul; 94():106383. PubMed ID: 32460059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TAM receptors Tyro3 and Mer as novel targets in colorectal cancer.
    Schmitz R; Valls AF; Yerbes R; von Richter S; Kahlert C; Loges S; Weitz J; Schneider M; Ruiz de Almodovar C; Ulrich A; Schmidt T
    Oncotarget; 2016 Aug; 7(35):56355-56370. PubMed ID: 27486820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptor tyrosine kinases Tyro3, Axl, and Mertk differentially contribute to antibody-induced arthritis.
    Gao L; He C; Yang A; Zhou H; Lu Q; Birge RB; Wu Y
    Cell Commun Signal; 2023 Aug; 21(1):195. PubMed ID: 37537628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tyro3 and CDK9 as biomarkers for drug resistance to breast cancer anti-PD-1 therapies].
    Zhang JF; Liu T
    Zhonghua Zhong Liu Za Zhi; 2023 Aug; 45(8):651-656. PubMed ID: 37580269
    [No Abstract]   [Full Text] [Related]  

  • 9. The TAM-family receptor Mer mediates production of HGF through the RhoA-dependent pathway in response to apoptotic cells.
    Park HJ; Baen JY; Lee YJ; Choi YH; Kang JL
    Mol Biol Cell; 2012 Aug; 23(16):3254-65. PubMed ID: 22740630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-phosphorylation, signaling and proliferative functions of the Tyro3 and Axl receptors in Rat2 cells.
    Brown JE; Krodel M; Pazos M; Lai C; Prieto AL
    PLoS One; 2012; 7(5):e36800. PubMed ID: 22606290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TYRO3 as a molecular target for growth inhibition and apoptosis induction in bladder cancer.
    Dufour F; Silina L; Neyret-Kahn H; Moreno-Vega A; Krucker C; Karboul N; Dorland-Galliot M; Maillé P; Chapeaublanc E; Allory Y; Stransky N; Haegel H; Menguy T; Duong V; Radvanyi F; Bernard-Pierrot I
    Br J Cancer; 2019 Mar; 120(5):555-564. PubMed ID: 30765874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Axl/Gas6/NFκB signalling in schwannoma pathological proliferation, adhesion and survival.
    Ammoun S; Provenzano L; Zhou L; Barczyk M; Evans K; Hilton DA; Hafizi S; Hanemann CO
    Oncogene; 2014 Jan; 33(3):336-46. PubMed ID: 23318455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MERTK Mediates Intrinsic and Adaptive Resistance to AXL-targeting Agents.
    McDaniel NK; Cummings CT; Iida M; Hülse J; Pearson HE; Vasileiadi E; Parker RE; Orbuch RA; Ondracek OJ; Welke NB; Kang GH; Davies KD; Wang X; Frye SV; Earp HS; Harari PM; Kimple RJ; DeRyckere D; Graham DK; Wheeler DL
    Mol Cancer Ther; 2018 Nov; 17(11):2297-2308. PubMed ID: 30093568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TAM family receptors in conjunction with MAPK signalling are involved in acquired resistance to PI3Kα inhibition in head and neck squamous cell carcinoma.
    Ruicci KM; Meens J; Plantinga P; Stecho W; Pinto N; Yoo J; Fung K; MacNeil D; Mymryk JS; Barrett JW; Howlett CJ; Boutros PC; Ailles L; Nichols AC
    J Exp Clin Cancer Res; 2020 Oct; 39(1):217. PubMed ID: 33059733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mer Tyrosine Kinase Regulates Disseminated Prostate Cancer Cellular Dormancy.
    Cackowski FC; Eber MR; Rhee J; Decker AM; Yumoto K; Berry JE; Lee E; Shiozawa Y; Jung Y; Aguirre-Ghiso JA; Taichman RS
    J Cell Biochem; 2017 Apr; 118(4):891-902. PubMed ID: 27753136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and role of TYRO3 and AXL as potential therapeutical targets in leiomyosarcoma.
    Dantas-Barbosa C; Lesluyes T; Loarer FL; Chibon F; Treilleux I; Coindre JM; Meeus P; Brahmi M; Bally O; Ray-Coquard I; Sunyach MP; Cesne AL; Mir O; Bonvalot S; Toulmonde M; Italiano A; Saintigny P; Jean-Denis M; Ducimetiere F; Ranchere D; El Sayadi H; Alberti L; Blay JY
    Br J Cancer; 2017 Dec; 117(12):1787-1797. PubMed ID: 29024938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophages and dendritic cells use different Axl/Mertk/Tyro3 receptors in clearance of apoptotic cells.
    Seitz HM; Camenisch TD; Lemke G; Earp HS; Matsushima GK
    J Immunol; 2007 May; 178(9):5635-42. PubMed ID: 17442946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphatidylserine and Tyro3-Axl-Mertk Receptor Tyrosine Kinase level detection in plasma and on plasma-derived extracellular vesicle surface in chronic lymphocytic leukemia.
    Bay M; Seval GC; Coskun O; Gurman G; Erdas NO
    Cell Biochem Funct; 2024 Jun; 42(4):e4035. PubMed ID: 38715180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticancer effect of luteolin is mediated by downregulation of TAM receptor tyrosine kinases, but not interleukin-8, in non-small cell lung cancer cells.
    Lee YJ; Lim T; Han MS; Lee SH; Baek SH; Nan HY; Lee C
    Oncol Rep; 2017 Feb; 37(2):1219-1226. PubMed ID: 28035396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autocrine role for Gas6 with Tyro3 and Axl in leiomyosarcomas.
    el Sayadi H; Pissaloux D; Alberti L; Tabone-Eglinger S; Ranchere D; Decouvelaere AV; Tabone E; Ray-Coquard I; Caux C; Fayette J; Blay JY
    Target Oncol; 2013 Dec; 8(4):261-9. PubMed ID: 23354874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.